Genome sequencing projects have provided researchers with an unprecedented boon of molecular information that promises to revolutionize our understanding of life and lead to new treatments of its disorders. However, genome sequences alone offer only limited insights into the biochemical pathways that determine cell and tissue function. These complex metabolic and signaling networks are largely mediated by proteins. The vast number of uncharacterized proteins found in prokaryotic and eukaroyotic systems suggests that our knowledge of cellular biochemistry is far from complete. Here, we highlight a new breed of 'postgenomic' methods that aim to assign functions to proteins through the integrated application of chemical and biological techniques.
One of the preeminent challenges facing twenty-first century scientists is the determination of the molecular, cellular and (patho)physiological functions for the numerous proteins encoded by eukaryotic and prokaryotic genomes. It is clear that this problem cannot be addressed by the analysis of genome sequences alone. Indeed, a significant fraction of every genome sequenced to date, from bacterial to human, is composed of uncharacterized proteins. Even those proteins for which tentative or apparently robust assignments of activity can be made are susceptible to reinterpretation as our understanding of the molecular complexity of life increases. For example, it is now clear that proteins with highly related sequences can perform different functions in vivo, and, conversely, proteins may show similar activities while lacking discernible sequence or structural similarity 1 . The additional realization that one gene can code for tens if not hundreds of different proteins as a result of post-transcriptional and post-translational processing and modification indicates that the number of proteins in need of characterization vastly exceeds the number of genes in the genome 2 . These various issues combine to present a formidable, but exciting, set of experimental problems for contemporary biological and chemical researchers, all of which distill down to predominantly a single question: how should we undertake the assignment of protein function in the postgenomic era?
The biochemical properties of proteins are typically determined in vitro with purified material. Although this classical 'test tube biochemistry' approach has succeeded in explaining the activities of many proteins, it does suffer some shortcomings. First, proteins do not function in isolation in vivo, but rather as parts of complex metabolic and signaling networks. Proteins are also regulated by post-translational mechanisms in vivo, including covalent modification and proteinprotein interactions (Fig. 1) . These dynamic events create a context dependency to the performance of proteins in living systems that can be difficult, if not impossible, to replicate in vitro. From a methodological perspective, in vitro studies are biased toward proteins that are more straightforward to express recombinantly and for which activity assays are available. As such, many challenging classes of proteins, including membrane-associated and uncharacterized proteins, are not effectively addressed by classical methods. Finally, the examination of individual proteins 'one at a time' is an uncomfortably slow process, especially when confronted with the thousands of proteins in current need of functional characterization.
The limitations of classical biochemical methods have inspired the development of tools and technologies that can, in a direct and systematic way, characterize the activities of proteins in complex biological settings. Among these 'systems biology' approaches, genetic techniques, such as targeted gene disruption (gene 'knockouts' 3 ) and RNA interference (RNAi) 4 , have proven particularly powerful, owing to their remarkable specificity and generality (Fig. 2) . Nonetheless, genetic methods suffer from a lack of temporal control over protein activity and are not well suited for dissecting the functions of different protein isoforms. The subject of this review is a distinct breed of systems biology methods that take advantage of chemistry, often in combination with genetic, protein biochemistry and analytical techniques, to tackle the problem of characterizing protein function on a global scale (Fig. 2) . As will be seen, a common trait of these methods is that they are truly 'postgenomic' in the sense that they require complete genome sequences for optimal performance. Thus, although the limitations of pure reliance on genome sequences will emerge as a recurring theme, these comments should not be viewed as a negative critique of genome sequencing efforts. On the contrary, the chemical biology approaches described herein provide perhaps the most profound endorsement of the value of complete genome sequences, which are enabling us to make experimental inquiries never before deemed possible.
function as large complexes to produce natural products with remarkable biological activities 5 . To date, more than 200 prokaryotic genomes have been fully sequenced, with many more projects under way (http:// www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl). This rich source of molecular information has spawned the birth of a new discipline termed 'genomic enzymology' to signify a movement away from singleenzyme phenomenology to the study of these proteins in the context of entire biological systems 1 . Genomic enzymology aims to integrate findings from multiple fields of research, including comparative genomics, structural biology and enzyme kinetics, to determine the functions of uncharacterized enzymes. This multidisciplinary approach has revealed several cases where the sequence, structure and function of enzymes diverge in surprising ways.
Divergent functions from similar sequences. The (β/α) 8 -(TIM) barrel, which is the most prevalent fold found among enzymes, has provided a fertile subject for postgenomic investigations 6 . Initiated with the discovery of two (β/α) 8 -barrel proteins, mandelate racemase and muconate lactonizing enzyme, that share conserved structures and active site functional groups, but catalyze different reactions 7 , this enzyme superfamily has since been shown to possess members that perform a wide range of mechanistically diverse chemical transformations. Thus, (β/α) 8 -barrel enzymes provide a clear case where gene or protein sequence alone cannot be used to predict function.
Complete genome sequences have afforded enzymologists the first opportunity to systematically compare (β/α) 8 -barrel proteins from distinct organisms in efforts to characterize their unique functions. This general strategy of comparative genomics 8 is particularly useful for prokaryotic organisms because their genes are often organized into operons, defined as a set of adjacent genes all under the transcriptional control of the same operator. Gerlt and colleagues have exploited 'genomic context' to predict activities for several uncharacterized (β/α) 8 -barrel enzymes. For example, the genes for YcjG and YkfB, two distantly related homologs of o-succinylbenzoate synthase (OSBS), were both found in the vicinity of genes involved in murein peptidoglycan metabolism 9 . Knowledge of this metabolic pathway, coupled with an understanding of the scope of potential reactions catalyzed by (β/α) 8 -barrel enzymes, led the researchers to propose that YcjG and YkfB are L-Ala-D/L-Glu epimerases (Fig. 3a) . Subsequent biochemical analysis of these proteins confirmed that they have L-Ala-D/L-Glu epimerase activity, representing the first examples of enzymes that catalyze this reaction. Notably, neither enzyme was able to catalyze the OSBS reaction, underscoring the remarkable functional diversity that can exist among sequence-related proteins.
Structural insights into the plasticity of (β/α) 8 -barrel proteins have been gained by a comparison of orotidine 5′-monophosphate decarboxylase (OMPDC) and 3-keto-L-gulonate 6-phosphate decarboxylase (KGPDC), two homologous enzymes that catalyze mechanistically unrelated reactions (metal-independent and Mg 2+ -dependent decarboxylations, respectively) 10 . An overlay of the active site structures of OMPDC and KGPDC revealed that conserved residues occupy nearly identical positions but serve distinct roles in catalysis. In OMPDC, these residues are involved in substrate binding, whereas in KGPDC they serve as ligands to coordinate a Mg 2+ ion required for stabilization of an enediolate anion intermediate (this intermediate is not formed in OMPDC-catalyzed decarboxylations). The authors conclude that OMPDC and KGPDC should be designated as members of a suprafamily to underscore that, even though these enzymes have significant sequence and structural similarity, they use distinct catalytic mechanisms (Fig. 3b) . More generally, these discoveries offer an instructive warning to those eager to predict the functions of uncharacterized proteins solely on the basis of sequence or structural information.
Examples of homologous enzymes that have disparate activities can also be found outside the (β/α) 8 -barrel family of enzymes. Whitman and colleagues have shown that different members of the 4-oxalocrotonate tautomerase (4-OT) family can catalyze not only tautomerase and isomerase, but also dehalogenase reactions 11, 12 . Pohl and colleagues have used innovative mass spectrometry (MS)-based substrate screening methods to determine that an archaeal enzyme originally annotated on the basis of sequence analysis as a glucose-1-phosphate deoxythymidylyltransferase is actually a bifunctional acetyltransferase-N-acetylglucosamine-1-phosphate uridylyltransferase 13 . Notably, the MS-based technologies described in this study should prove of general value for the rapid and systematic biochemical characterization of new carbohydraterelated enzymes encoded by prokaryotic and eukaryotic genomes.
Similar functions from divergent sequences. Genomic enzymologists have also uncovered interesting cases where enzymes that share no sequence or structural similarity perform similar functions. For example, Begley and colleagues used comparative genomic analyses to identify the first tryptophan-to-quinolinate pathway in bacteria 14 , thereby dispelling the generally held belief that this process is unique to eukaryotes. Before this discovery, prokaryotes were assumed to biosynthesize quinolinate exclusively from aspartate and dihydroxyacetone Metabolomics phosphate. However, screening of genome archives identified clusters of neighboring genes encoding homologs of key enzymes involved in the eukaryotic tryptophan-to-quinolinate pathway in multiple bacterial species. These bacterial enzymes were shown to produce quinolinate from tryptophan by both biochemical and genetic methods. The predictive power of genomic context was once again exploited to identify an unannotated gene with a metal-dependent hydrolase sequence as the N-formylkynurenine formamidase component of the bacterial tryptophan-to-quinolinate pathway. These studies demonstrate that bacteria can produce quinolinate, the universal de novo precursor to the pyridine ring of NAD, through at least two distinct routes whose enzymatic constituents share no sequence, structural or mechanistic homology.
Dunaway-Mariano and colleagues have also provided an intriguing example of sequence-unrelated enzymes that perform similar reactions. By comparing the 4-chlorobenzoate (4-CBA) dehalogenation pathway operons from different bacteria, the authors readily identified conserved sequence homologs responsible for the 4-CBA-coenzyme A (4-CBA-CoA) ligase and 4-CBA-CoA dehalogenase activities in this pathway 15 . Notably, however, the 4-hydroxybenzoate-CoA thioesterase activity was found to be catalyzed by distinct sets of sequence-unrelated enzymes (Fig. 3c) . This divergence in protein sequences among 4-CBA pathways from different bacteria suggests that they did not, as originally suspected, evolve as a recent adaptation to exposure to industrially produced 4-CBA, leading the authors to speculate that natural sources of 4-CBA may exist.
Proteomic methods for the assignment of protein function
The comparative genomics methods described above are extremely powerful for prokaryotic organisms, where genes of related function are often spatially linked in the genome. However, additional technologies are needed to facilitate the global characterization of proteins encoded by eukaryotic genomes. These technologies generally fit under the term proteomics 16, 17 . The daunting size and diversity of eukaryotic proteomes has inspired efforts to profile specific classes of proteins on the basis of shared functional properties 18 . Within this realm of 'targeted proteomics' , chemical strategies are emerging as a powerful approach to analyze protein function in complex biological systems 19, 20 .
Profiling enzyme activities in proteomes. Conventional genomic and proteomic methods comparatively quantify the expression levels of transcripts 21 and proteins 22 (b) OMPDC and KGPDC are homologous enzymes that catalyze mechanistically distinct reactions using different substrates 10 . OMPDC decarboxylates orotidine 5′-monophosphate in a metal-independent manner, whereas KGPDC catalyzes the metal (Mg 2+ )-dependent decarboxylation of 3-keto-L-gulonate 6-phosphate. These intriguing differences have led to the proposal that these enzymes be considered members of a suprafamily, to designate that they share significant sequence similarity but use distinct catalytic mechanisms. (c) The 4-hydroxybenzoate-CoA (HBA) thioesterase enzymes in the 4-chlorobenzoate dehalogenation pathways of Arthrobacter and Pseudomonas share no sequence homology but perform the same reaction 15 . [24] [25] [26] , that uses active site-directed probes to read out the functional state of large numbers of enzymes directly in whole proteomes (Fig. 4a) . ABPP probes selectively label active enzymes but not their inactive (for example, zymogen or inhibitor-bound) forms 27 , facilitating the characterization of changes in enzyme activity that occur in the absence of alterations in protein or transcript expression 25, 28, 29 . Additionally, because ABPP probes label enzymes on the basis of shared catalytic properties rather than mere expression level, they provide data sets enriched in low-abundance proteins that can be read out in a range of formats, including gels 28, 29 , microarrays 30 , liquid chromatography 31 , and capillary electrophoresis 32 . These features have enabled ABPP to be applied to a wide range of biological samples, permitting, for example, the identification of new enzyme activities elevated in aggressive cancer cells and tumors 28, 33, 34 , invasive malaria parasites 35 and obese livers 36 .
To date, we and others have generated ABPP probes for more than 20 enzyme classes, including members of all major families of proteases (serine 24 , cysteine [37] [38] [39] [40] [41] , metallo 42, 43 , aspartyl 44 , proteasomal 45, 46 ), phosphatases 47, 48 , kinases 49 , glycosidases 50 and glutathione S-transferases 51 and a range of oxidoreductases 31,51-53 ( Table 1) . These probes have derived from a combination of two complementary approaches, referred to as directed and nondirected ABPP 54 . In directed ABPP, probes are designed to target a specific class of enzymes by the incorporation of known affinity labels and/or binding groups into their structures. Directed probes can achieve covalent modification of enzyme active sites by either electrophilic labeling of complementary nucleophilic residues 24,37-41,45,46 or photo-cross-linking [42] [43] [44] . Because each directed probe typically targets a large set of mechanistically related enzymes, they have enabled the identification of unannotated members of enzyme superfamilies that could not be classified by sequence analysis 55, 56 . In nondirected ABPP, combinatorial libraries of candidate probes are synthesized and screened against complex proteomes to identify specific protein labeling events. Nondirected ABPP probes have used diverse reactive groups, including sulfonate esters 51, 52 and α-chloroacetamides 36 ( Table 1) , to target several mechanistically distinct enzyme classes. Detailed analyses have provided strong evidence that, in most cases, nondirected ABPP probes selectively label the active sites of their enzyme targets 31 , indicating that they should provide an accurate assessment of the functional state of these proteins in proteomes.
Although promiscuous probes are of great value for profiling many enzyme activities in parallel, the assignment of protein function also relies on the development of specific reagents to perturb individual members of large enzyme classes. Toward this end, ABPP has proven effective as a primary screen for the discovery of both reversible 57 and irreversible 29, 58 enzyme inhibitors (Fig. 4b) . Inhibitor screening by ABPP has several advantages over conventional substrate assays. First, enzymes can be assayed in their native proteomic context without the need for recombinant expression or purification. Second, inhibitors can be developed for uncharacterized enzymes that lack known substrates 57 . Finally, because inhibitors are evaluated against many enzymes in parallel, selective agents can be readily discriminated from nonspecific compounds that target many enzymes. Inhibitor screening by ABPP has culminated in the design of selective covalent probes for several proteases, which have been used to test the function of these enzymes in living systems and as in vivo imaging agents 29, 34 .
One drawback of the original ABPP method is that probes were encumbered with a large reporter tag, which can perturb their cellular uptake and distribution. Tag-free versions of ABPP were recently introduced that exploit either the Huisgen's azide-alkyne cycloaddition reaction (click chemistry) 59 or the Staudinger ligation 46 to attach the reporter group to activity-based probes after the covalent labeling of protein targets. These advanced ABPP approaches have been used to profile enzyme activities in vivo, resulting in the discovery of enzymes that are selectively labeled in living cells, but not in vitro 60 .
Profiling post-translational modifications in proteomes. Chemical strategies have also been developed to profile many types of post-translational modifications (PTMs) in cells and tissues. Protein phosphorylation events dynamically regulate the function of numerous intracellular proteins and cell signaling pathways 61 . Phosphorylation sites are difficult to predict from sequence analysis alone; therefore, a major goal of proteomics is to comprehensively map this PTM in both space and time in cells and tissues. The Aebersold and Chait groups have described methods to chemically tag phosphorylated peptides in proteomes for their selective enrichment and characterization 62, 63 . In the Aebersold approach, phosphopeptides are converted to phosphoramidates, which are then conjugated with cystamine and captured by reaction with iodoacetyl groups immobilized on a solid support 62 (Scheme 1a, left). Chait and colleagues induced the base-catalyzed β-elimination of phosphoserine and phosphothreonine residues to dehydroalanine, which could then serve as a Michael acceptor for ethanedithiol and subsequently be modified with a maleamide biotin tag 63 (Scheme 1a, right). Each of these approaches has distinct advantages and limitations, with the Aebersold method being applicable to all three types of phosphorylation (serine, threonione, tyrosine) but requiring more steps, whereas the Chait method is more efficient, but not applicable to phosphotyrosine and susceptible to cross-reaction with O-linked N-acetylglucosamine (O-GlcNAc)-modified peptides (see later discussion). Notably, a creative variant of this latter approach was recently introduced by the Hathaway and Shokat groups, who showed that dehydroalanine peptides can be modified with cysteamine to create trypsin cleavage sites for phosphorylation mapping by selective proteolysis 64, 65 (Scheme 1a).
Another dynamic PTM that is gaining considerable interest among cell biologists is the O-GlcNAc modification of serine and threonine residues 66 . O-GlcNAc has been shown to modulate a range of cellular processes, including proteasomal degradation 67 and gene silencing 68 .
Like phosphorylation, O-GlcNAc modifications are dynamic and cannot be easily predicted from the analysis of protein sequences; thus, technologies are needed for their direct identification in complex cell and tissue preparations. Hart and colleagues showed that O-GlcNAc modifications can be selectively eliminated over phosphorylation sites under mild basic conditions, thus making them susceptible to analysis through the Michael acceptor chemical tagging method described above 69 . More recently, the Bertozzi and Hsieh-Wilson groups have described alternative strategies for tagging and enriching O-GlcNAcmodified proteins from proteomes. Bertozzi and colleagues treated cells with N-azidoacetylglucosamine (GlcNAz), resulting in the in situ delivery of a bio-orthogonal group (azide) to sites of O-GlcNAc modification in the proteome 70 (Scheme 1b). GlcNAz-modified proteins could then be derivatized through the Staudinger ligation with a reportertagged triarylphosphine ester for purification and characterization. Notably, the Bertozzi group and others have exploited this metabolic labeling method to profile additional PTMs, including mucin-type O-linked glycosylation 71 and lipid modifications such as farnesylation 72, 73 . Hsieh-Wilson and colleagues have taken a different approach and engineered a β-1,4-galactosyltransferase to append a ketone-containing galactose selectively onto the C-4 hydroxyl of GlcNAc 74 (Scheme 1c). These ketone-tagged proteins are then reacted with an aminooxy biotin reagent to allow their affinity purification by avidin chromatography 75 . One advantage of this strategy is that it can be applied to any proteomic sample, including those not readily amenable to metabolic engineering. For example, 25 O-GlcNAc-modified proteins were identified from rat forebrain, 23 of which were not previously known to be modified with this carbohydrate 75 . Finally, a chemical labeling approach involving oxidative cleavage and hydrazide reaction on solid phase has been developed to profile N-linked glycoproteins 76 . The inclusion of an isotopelabeling step permitted comparative quantification of glycoproteins in different proteomic samples.
In summary, chemical tagging has emerged as a preferred strategy for the selective enrichment and characterization of a range of PTMs in proteomes. The molecular information garnered by these approaches extends far beyond that which can be gleaned from standard genomics or proteomics. It should also be noted that the success of chemical proteomic methods has been bolstered by tremendous advances in the sensitivity and accuracy of modern protein MS techniques 22 . We anticipate that chemical proteomics will continue to play an integral part in the inventorying of PTMs and assessment of the dynamic manner in which these events regulate protein function in vivo.
Engineering specific enzyme-inhibitor pairs. Enzyme superfamilies present an intriguing paradox for postgenomic researchers. On the one hand, recognition from sequence, structural and/or biochemical analyses that a protein belongs to a particular enzyme class restricts its potential activities in vivo and therefore should, in principle, facilitate functional characterization. However, the daunting size of enzyme superfamilies complicates experimental efforts to assign unique physiological activities to individual members. For example, classical genetic approaches, such as targeted gene disruption, are susceptible to compensatory changes by other superfamily members that mask enzyme function. Likewise, inhibitors of enzymes from large classes often lack the requisite selectivity for in vivo pharmacological application 77 . Recently, chemical biology strategies have been introduced that integrate the complementary power of organic synthesis and protein engineering to create tools for investigating the function of individual members of enzyme superfamilies.
Protein kinases constitute the largest enzyme class in mammalian proteomes and are key elements of most, if not all, signal transduction pathways that regulate cell physiology and pathology 78 . With more than 500 members encoded by the human genome, many still uncharacterized, the 'kinome' constitutes a rich source for future biological discovery and pharmaceutical intervention. To facilitate the functional characterization of kinases, Shokat and colleagues have devised a general method to genetically engineer variants of these enzymes that interact with synthetic inhibitors and substrates not recognized by wild-type kinases 79, 80 . Remarkably, these 'analog-sensitive' (as) kinases can often be created by mutation of a single active site residue, referred to as the 'gatekeeper' residue. Conversion of this typically bulky residue to smaller amino acids, such as glycine, creates a 'hole' in the active site that can accept inhibitors and substrates (for example, ATP analogs) bearing large substituents ('bumps') that sterically clash with wild-type kinase binding pockets (Fig. 5a) . This approach is referred to as chemical genetics to signify that kinases have been genetically The ketone is then reacted with a reporter TAG-oxime to enable affinity enrichment and characterization.
engineered for sensitivity to specific chemical reagents. Chemical genetics has been successfully implemented to test the roles of many kinases in signaling events, both in culture and in vivo. For example, chemical inhibition of an as mutant of the budding yeast kinase Prk1p revealed a role for this protein in regulating actin patches involved in endocytosis 81 . An as mutant of CamKIIα was introduced by transgenic methods selectively into the forebrains of mice, providing evidence that the activity of this kinase is required during the first postlearning week for memory consolidation 82 . Both of these studies highlight one of the primary advantages of chemical genetic methods, namely, tight temporal control over dynamic, kinase-regulated cellular and behavioral processes. An additional benefit was demonstrated by Witte and colleagues, who showed that chemical genetics can be used to infer the mechanism of action of kinase-directed inhibitors 83 . Specifically, selective inhibition of an as variant of the oncogenic kinase BCR-ABL did not eliminate immature myeloid leukemic cells, which contrasts with the cytotoxic effects of the BCR-ABL-directed inhibitor imatinib mesylate (Gleevec) in these cells (Fig. 5b) . These results suggest that the therapeutic efficacy of imatinib is caused by the inhibition of multiple kinases in addition to BCR-ABL (for example, KIT, which is also expressed in immature myeloid leukemic cells). Finally, as variants can also be used in combination with ATP analogs to profile kinase substrate selectivity in proteomic extracts, as exemplified by the studies of Morgan and colleagues on the cyclin-dependent kinase Cdk1 (ref. 84) .
Given the impressive success of chemical genetic applications to kinases, an obvious next question is whether this approach can be generally extended to other enzyme superfamilies. Although studies that speak to this issue are still relatively scarce, initial results with ATPases 85 , GTPases 86, 87 , cyclophilins 88 and phosphatases 89 are encouraging. Indeed, an as variant of myosin 1c has revealed a specific role for this motor protein in controlling adapative responses in hair cells of the inner ear 85 . Moreover, recent advances reported by Shokat and colleagues to address kinase family members intolerant to original gatekeeper mutations offer methodological and biophysical guidelines that should assist future chemical genetics endeavors relating to this enzyme family and others 90 .
Engineering specific post-translational modifications in proteins.
The historical view of a one-to-one relationship between gene and protein has been replaced by the provocative realization that numerous protein products derive from a single gene 2 . These protein variants arise by multiple mechanisms, including alternative splicing, proteolytic processing and PTM. Accordingly, as described above, a major goal of proteomics is to inventory these epigenetic events to achieve a more comprehensive understanding of the diversity of protein species that exist in vivo. However, an equally if not more important problem is to determine the unique functions performed by different protein isoforms. Indeed, the current (and rapidly expanding) catalog of PTMs far exceeds the number of cases where the physiological significance of these events has been deduced. The ability to create homogeneous preparations of proteins bearing specific PTMs is essential for their biochemical and cell biological characterization. Multiple chemical biology research programs have been initiated with this goal in mind. Cole, Muir and colleagues have pioneered the development and application of expressed protein ligation (EPL) methods for the semisynthesis of post-translationally modified proteins. These approaches exploit the versatile native chemical ligation reaction, in which two protein fragments, one containing a C-terminal thioester (generated through fusion to an intein protein) and the other containing an Nterminal cysteine, react and rearrange through an S-to-N acyl shift to form a native peptide bond 91 (Scheme 2a). Significantly, protein substrates for EPL can derive from recombinant or synthetic sources, greatly expanding the range of chemical modifications that can be site-specifically incorporated into proteins. Cole and colleagues have used EPL to generate homogeneous preparations of singly and doubly phosphorylated forms of the tyrosine phosphatase SHP-2 (refs. 92,93) . In these studies, a nonhydrolyzable phosphotyrosine mimetic was incorporated into SHP-2, permitting dissection of the roles of specific phosphorylation events in regulating the biochemical and cellular activity of this phosphatase. Muir and colleagues have exploited EPL to decipher the contribution of individual phosphorylation events to the oligomerization of Smad2 and its recognition as a substrate for transforming growth factor β kinase 94 .
Chemical approaches have also been devised for the creation of caged phosphopeptides or phosphoproteins, allowing exquisite spatial and temporal control over their function in vitro and in living cells. Bayley and colleagues have described the semi-synthesis of thiophosphorylated variants of protein kinase A (PKA), which is accomplished by incubation of this protein with a kinase in the presence of ATP(γ)S 95 (Scheme 2b). The thiophosphoryl group can then be selectively caged on the basis of its enhanced nucleophilicity. Thiophosphoryl groups have the advantage of being resistant to phosphatase cleavage and thus show enhanced stability in living cells. One limitation of this approach, however, is that enzyme-catalyzed thiophosphorylation reactions do not yet constitute a generally applicable way to generate any phosphorylated protein.
Imperiali and colleagues have pioneered a complementary approach that uses versatile 1-(2-nitrophenyl) ethyl-modified serine, threonine and tyrosine building blocks for the synthesis of caged phosphoproteins or phosphopeptides 96, 97 (Scheme 2c). These caged phosphoamino acids can be incorporated into proteins or peptides through several mechanisms, including direct synthesis 97 , in vitro translation using nonsense suppression methods 98 and EPL 99 . Imperiali, Yaffe and colleagues have applied caged phosphopeptides to disrupt the function of the 14-3-3 proteins in living cells 100 . Notably, with the use of a consensus phosphopeptide motif that interacts with all 14-3-3 proteins (Scheme 2c), this chemical biology approach allowed the synchronous inactivation of an entire family of adaptor proteins, a task that would have been difficult to accomplish with traditional genetic methods.
Finally, Lawrence and colleagues have shown that the activity of the actin-severing protein cofilin can be controlled by mutagenesis of a serine phosphorylation site to either cysteine (active) or a caged cysteine variant modified with α-bromo-(2-nitrophenyl) acetic acid (inactive) 101 (Scheme 2d). Photoactivation of the caged profilin in living cells revealed new roles for this protein in actin-based cytoskeletal dynamics. This approach may prove generally useful for studying the activity of proteins that are negatively regulated by phosphorylation.
It is clear from the examples provided here that chemical biology approaches offer powerful methods and tools to test the functional significance of specific PTMs. To date, most of these studies have focused on protein phosphorylation, and it will be exciting to witness as approaches such as EPL and caged amino acid derivatives are extended to the analysis of additional PTMs. Toward this end, the ability to sitespecifically incorporate a range of amino acid derivatives into proteins remains a paramount objective. Additionally, many proteins, such as integral membrane proteins, are not easily produced in purified form through either chemical synthesis or recombinant expression. Recent advances by the Schultz and Muir groups that extend technologies such as non-natural amino acid incorporation 102, 103 and EPL 104 to in vivo settings should expand the spectrum of post-translationally modified proteins amenable to molecular and cellular analysis.
Metabolomic methods for the assignment of protein function
A protein's function can be defined on many levels-molecular, cellular and physiological. Although these functions are all interrelated (for example, an enzyme performs chemistry to generate a product (molecular) that affects a cell (cellular), which in turn affects the higher organism (physiological)), the technologies required for their experimental investigation are distinct. For example, genetic approaches such as gene knockouts 3 and RNAi 4 , as well as the proteomic methods delineated in the previous section, can be combined with cell-and organismbased phenotypic screens to characterize the cellular and physiological functions of proteins. However, the endogenous biochemical activities of proteins are less straightforward to address with these methods. For enzymes, in particular, the identification of natural substrates often remains an elusive goal. Recent advances in global metabolite profiling offer powerful new ways to address this problem.
Enzymes regulate biological processes through the conversion of specific substrates to products. Therefore, the identification of an enzyme's full complement of physiological substrates is of paramount importance. The systematic characterization of endogenous substrates of enzymes requires the advancement of new technologies that can broadly profile the molecular composition of cells and tissues. The field of metabolomics has emerged with this objective in mind. Metabolome researchers are confronted with several technical challenges that, in many ways, surpass those of genomics and proteomics. First, as opposed to transcripts and proteins, metabolites are not directly linked to the genetic code, but are instead the products of the concerted action of complex enzymatic networks. Similarly, metabolites are not linear polymers composed of a defined set of monomers, but rather a remarkably diverse collection of structures with differing chemical and physical properties. These distinguishing features have inspired the development of both targeted and untargeted analytical methods for metabolite profiling that, when coupled with genomic and proteomic technologies, provide a powerful platform for forging direct connections among enzymes, substrates and the higher-order physiological processes they regulate.
Assignment of enzyme function by targeted metabolite profiling.
Targeted metabolomic experiments have proven effective at characterizing the physiological relationship between a defined set of enzymes and natural products. For example, by profiling the metabolic consequences of disrupting distinct phenylalanine ammonia lyase (PAL) enzymes in Arabidopsis thaliana, Rhode and colleagues succeeded in differentiating their unique biochemical functions 105 . PAL enzymes had long been recognized to participate in the biosynthesis of the phenylpropanoid class of natural products (for example, lignins, flavonoids, coumarins); however, which PAL enzymes performed these chemical transformations in vivo has remained unclear. Targeted liquid chromatographyultraviolet (LC-UV) spectroscopy revealed a primary role for PAL1 in the biosynthesis of phenylpropanoids, with a secondary role for PAL2 (Scheme 3a). The authors also performed complementary genomic studies on PAL gene mutants, leading to the identification of additional metabolic pathways altered in these organisms. These results provided the first global view of the extent to which individual PAL enzymes are integrated into the larger metabolic networks of plant cells.
Targeted metabolite profiling has also been used as a screen to 'molecularly phenotype' mutant organisms originating from forward genetic screens. Wu and colleagues profiled plasma amino acid and acylcarnitine levels in ethylnitrosourea (ENU)-treated mice by direct-inject tandem MS analysis, resulting in the discovery of a mutant mouse line with highly elevated levels of branched-chain amino acids (BCAAs) 106 . These mice also showed signs of wasting (reduced body weight and motility). Similar phenotypes are observed in humans with defects in branchedchain α-keto acid dehydrogenase (BCKD), leading to maple syrup urine disease. Surprisingly, however, the mutant mice did not show reduced BCKD activity, but rather a loss in the function of the mitochondrial branched-chain aminotransferase (mBCAT) enzyme, which converts BCAAs to branched-chain α-keto acids (Scheme 3b), the natural substrates of BCKD. These results indicate that the disruption of one of multiple enzymes in the BCAA biosynthetic pathway leads to a common set of metabolic and physiological defects.
Assignment of enzyme function by untargeted metabolite profiling. The targeted profiling methods described above provide a robust and sensitive way to quantify known metabolites in complex biological samples. However, these approaches are not suited for the discovery of new metabolites and may therefore fail to report on the full spectrum of substrates used by a given enzyme in vivo. To address this problem, we have recently introduced a complementary liquid chromatographymass spectrometry (LC-MS)-based strategy for 'untargeted' metabolomics referred to as discovery metabolite profiling (DMP) 107 . In contrast to targeted LC-MS, in which the levels of specific metabolites are measured by selected ion monitoring (SIM) in conjunction with isotopic standards, DMP operates as a global, standard-free method, where the relative levels of numerous metabolites are quantified in parallel by the direct measurement of their mass ion intensities in a broad mass scanning mode (Fig. 6) .
DMP was applied to characterize the tissue metabolomes of wildtype mice and mice lacking the enzyme fatty acid amide hydrolase [FAAH -/-mice], which degrades the N-acyl ethanolamine (NAE) class of signaling lipids in vivo (Scheme 3c), including the endocannabinoid anandamide 108 . Consistent with previous targeted LC-MS studies 109 , DMP accurately measured an approximately ten-fold increase in the central nervous system (CNS) levels of NAEs in FAAH -/-mice. The detection of low-abundance NAEs such as anandamide indicated that DMP maintained good sensitivity (estimated to be within one order of magnitude of targeted methods). Interestingly, DMP also detected a second class of CNS metabolites that were highly elevated in FAAH -/-mice. These metabolites did not belong to any of the known classes of endogenous lipids, suggesting that they constituted new natural products. This premise was confirmed by subsequent analytical and synthetic chemistry efforts, which identified the uncharacterized class of FAAH-regulated lipids as conjugates of fatty acids and the amino acid taurine [N-acyl taurines (NATs)] (Scheme 3c). The function of the FAAH-NAT metabolic pathway in mammalian biology is under active investigation. Finally, other major classes of known lipids, including fatty acids, phospholipids, monoacylglycerols and ceramides, were not altered in FAAH -/-mice, supporting a specific role for this enzyme in the metabolism of endogenous amidated lipids. These results underscore the power of untargeted profiling methods such as DMP, which can provide a more comprehensive portrait of the endogenous substrates of enzymes and, through doing so, illuminate unanticipated connections between the proteome and metabolome.
Untargeted metabolite profiling has more recently been implemented, in combination with gene-expression profiling, to identify a class of sulfotransferases involved in glucosinolate (GLS) metabolism in plants 110 . The GLS metabolic pathway has been an active subject of research for many years, and most of its participating enzymes had been 138 VOLUME 1 NUMBER 3 AUGUST 2005 NATURE CHEMICAL BIOLOGY previously characterized, with the exception of the sulfotransferases. Saito and colleagues monitored in an untargeted manner the timedependent changes in the metabolome and transcriptome induced by sulfur deprivation using Fourier transform MS and DNA microarrays, respectively. A collection of GLS metabolites and known biosynthetic genes were found to show similar expression profiles. Interestingly, within this collection of coregulated genes, the authors also found three putative sulfotransferases. Recombinant expression and biochemical analysis demonstrated that these proteins can indeed convert desulfoallyl GLS to sulfonated allyl GLS (Scheme 3d, red), confirming their identification as GLS sulfotransferases. These findings indicate that the integration of metabolomic and transcriptomic data can reveal functions for uncharacterized enzymes.
In summary, global metabolite profiling methods provide access to a valuable portion of biomolecular space that is largely inaccessible to genomic and proteomic methods. Significantly, much of the information provided by metabolomics, especially as relates to protein function assignment, may be difficult if not impossible to procure by classical biochemical methods. For example, the substrate selectivity of FAAH, as determined in vitro with purified preparations of enzyme, was largely unpredictive of the substrates used by this enzyme in vivo 107 . These findings reinforce the importance of characterizing enzymes within the context of the cells and tissues in which they are naturally expressed, where potentially competitive and/or interdependent metabolic pathways are taken into account. Future efforts will probably focus on expanding the portion of the metabolome that is addressable by DMP methods. Lipids, which can be enriched by organic extraction, were an obvious first target. The extension of DMP to other classes of metabolites will require the advent of methods for their selective enrichment. Another important challenge will be to devise ways to accelerate the determination of metabolite structures, possibly through the creation of searchable databases that contain the chemical and physical features of all known metabolites (for example, their mass fragmentation patterns, solvent solubility profiles, susceptibility to chemical modification). Solutions to these provocative problems, which may very well come from the field of chemical biology, should greatly enhance our understanding of how enzymes and their substrates interact to form the higher-order metabolic and signaling networks that govern cell and organismal behavior.
Summary and Future Directions
In this review, we have attempted to achieve two major goals. First, we hope to have captured the remarkable power of integrated chemical and biological approaches (dubbed 'chemical biology') for the determination of protein function. Whether it be the characterization of new metabolic pathways in bacteria, or the identification of enzyme activities and protein PTMs in mammalian proteomes, or the discovery of physiological substrates of enzymes, chemical biology efforts are perhaps best defined by their motivation to unite methods and tools from historically separate disciplines. This integrated approach, where complementary techniques such as genetics, protein engineering, organic synthesis and analytical chemistry are brought to bear on a single research problem, has allowed inquiries into the functional state of proteins in highly complex biological samples, providing insights into their molecular, cellular and physiological activities that extend far beyond the information accessible to any individual discipline.
Our second objective was to illuminate the essentiality of genome sequences to research endeavors that aim to describe protein function on a systematic and global scale. Indeed, many of the technologies described in this review are founded in classical experimental approaches, such as operon analysis, affinity labeling and site-directed mutagenesis. However, their conversion into global strategies for the characterization of protein function was only possible with the availability of complete genome sequences. For example, the sequencing of several hundred bacterial genomes has fostered the emergence of new fields of research, such as genomic enzymology, where biochemical, structural and comparative genomic methods converge to reveal unexpected functional relationships among members of enzyme super-and suprafamilies. Likewise, the molecular information procured by chemical proteomic investigations of protein activity and PTM state would be virtually uninterpretable without searchable databases of MS fragmentation patterns of all proteins encoded by a given genome. Finally, and perhaps most importantly, genome sequences provide a context in which to evaluate the full complement of proteins from a given family to discern their unique and overlapping functions. In this regard, enzymes such as kinases and hydrolases, for which there are several hundred representatives in the human genome, stand as a humbling reminder of how much still remains to be learned about even the most 'familiar' classes of proteins. In looking to the future, we recognize several challenges that confront researchers interested in applying postgenomic methods to the functional characterization of proteins. First, as the reader has probably noticed, this review has placed a disproportionate emphasis on enzymes over other types of proteins. We believe that this bias is rooted in several factors. First, the function of enzymes, which generally equates with catalytic activity, is, at least on first pass, simpler to define than for many other proteins. Enzymes also possess well-defined active sites, which harbor conserved catalytic residues that can be exploited to create class-wide approaches for experimental analysis (for example, sites for comparative sequence alignment, affinity labeling or mutagenesis). Nonetheless, we anticipate that many of the principles established for the postgenomic examination of enzymes can be extended to other types of proteins, such as receptors and ion channels, which also share common molecular and structural features that should make them vulnerable to unified strategies for functional characterization.
A more general problem relates to the somewhat arbitrary definition of 'protein function' itself, which can vary depending on the mode of scientific investigation. Indeed, it is becoming clear that many proteins in both prokaryotic and eukaroytic organisms have been misannotated on the basis of a cursory inspection of their sequences 111 . Although increasingly sophisticated sequence analysis programs such as Shotgun 112, 113 should help to rectify these errors, experimental approaches still stand as the only satisfactory way to verify the actual activities performed by proteins. Several of the methods described in this review use molecular engineering to create specific variants of proteins for functional analysis. Although these approaches offer the compelling advantage of isolating one protein (or even one PTM state of a protein) for characterization in complex biological settings, they generally involve heterologous expression systems and, thus, often do not address the function of proteins in their native environment. In contrast, chemical profiling methods can be applied to any biological system (even primary human biopsies) to assess the functional state of natively expressed proteins. However, these profiling technologies provide only an associative relationship between the activity or PTM state of proteins and a particular (patho)physiological event. Follow-up studies are needed to deduce whether the identified proteins actually contribute to the higher-order processes under investigation. Given that molecular engineering and chemical profiling methods possess complementary strengths and weaknesses, we suggest that future chemical biology efforts be aimed at fully developing these technologies such that a complete spectrum of experimental approaches is available for the functional characterization of all protein classes in the proteome. Before the achievement of this ultimate goal, we can be satisfied with the fact that chemistry, by providing unique reagents and methods for interrogating the function of proteins in complex biological systems, promises to have a prominent role in most, if not all, forms of postgenomic inquiry. In Table 1 , all reference numbers should be increased by 1, as shown. 
